Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Biosemantic graph transfer learning for cross-patient cell type annotation and cell-cell interaction analysis in tumor single-cell RNA sequencing.

Created on 13 Nov 2026

Authors

Yue-Chao Li, Leon Wong, Hai-Ru You, Xin-Fei Wang, Meng-Meng Wei, Lei Wang, Zhi-An Huang, Yu-An Huang, Zhu-Hong You

Published in

Briefings in bioinformatics. Volume 27. Issue 6. Nov 02, 2026.

Abstract

The exploration of cellular heterogeneity within the tumor microenvironment (TME) via single-cell RNA sequencing (scRNA-seq) is essential for understanding cancer progression and response to therapy. Current scRNA-seq approaches, however, lack spatial context and rely on incomplete datasets of ligand-receptor interactions, limiting accurate cell type annotation and cell-cell communication inference. This study addresses these challenges using a novel graph neural network model that enhances cell-type prediction and cell-interaction analysis. Our study utilized a dataset consisting of 49 024 cells from 19 patients across three cancer types: leukemia, breast invasive carcinoma, and colorectal cancer. The proposed scGSL model demonstrated robust performance, achieving an average accuracy of 84.83%, precision of 86.23%, recall of 81.51%, and an F1 score of 80.92% across all datasets. These metrics represent a significant enhancement over existing methods, which typically exhibit lower performance metrics. Additionally, by reviewing existing literature on gene interactions within the TME, the scGSL model proves to robustly identify biologically meaningful gene interactions in an unsupervised manner, validated by significant expression differences in key gene pairs across various cancers. The source code and data used in this study can be found at https://github.com/LiYuechao1998/scGSL.

PMID:
43021601
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement